Cargando…
Personalizing prostate cancer diagnosis with multivariate risk prediction tools: how should prostate MRI be incorporated?
Risk-based patient selection for systematic biopsy in prostate cancer diagnosis has been adopted in daily clinical practice, either by clinical judgment and PSA testing, or using multivariate risk prediction tools. The use of multivariable risk prediction tools can significantly reduce unnecessary s...
Autores principales: | Schoots, Ivo G., Padhani, Anwar R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064475/ https://www.ncbi.nlm.nih.gov/pubmed/31399825 http://dx.doi.org/10.1007/s00345-019-02899-0 |
Ejemplares similares
-
Multivariate risk prediction tools including MRI for individualized biopsy decision in prostate cancer diagnosis: current status and future directions
por: Schoots, Ivo G., et al.
Publicado: (2019) -
Delivering Clinical impacts of the MRI diagnostic pathway in prostate cancer diagnosis
por: Schoots, Ivo G., et al.
Publicado: (2020) -
Risk‐adapted biopsy decision based on prostate magnetic resonance imaging and prostate‐specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation
por: Schoots, Ivo G., et al.
Publicado: (2020) -
Clinical applications of multiparametric MRI within the prostate cancer diagnostic pathway()
por: Dickinson, Louise, et al.
Publicado: (2013) -
From PROMIS to PRO-MRI in primary prostate cancer diagnosis
por: Schoots, Ivo G., et al.
Publicado: (2017)